How Umbilical Cord MSCs May Influence Inflammation in Ulcerative Colitis

In this episode, we explore how umbilical cord-derived mesenchymal stem cells (UC-MSCs) may help influence inflammation in ulcerative colitis by targeting immune dysfunction at its source. Learn how these cells work, what clinical research shows, and why UC-MSC therapy is gaining attention as a potential option for people living with chronic inflammatory bowel disease.

You’ll learn:

• What makes umbilical cord-derived mesenchymal stem cells different from other stem cell sources
• Why Wharton’s jelly is considered a preferred source for MSC therapy
• How UC-MSCs locate and respond to inflamed tissue in ulcerative colitis
• The role of immune modulation, T-cell balancing, and regulatory T cells in reducing inflammation
• How macrophage repolarisation from M1 to M2 may support healing and tissue repair
• Why is protecting and restoring the intestinal epithelial barrier important in ulcerative colitis
• What the Disease Activity Index (DAI) measures and what clinical studies reveal about treatment outcomes
• How UC-MSC therapy may contribute to mucosal healing and long-term immune rebalancing
• The similarities between ulcerative colitis and Crohn’s disease when it comes to MSC therapy mechanisms
• How Cyrona uses Wharton’s jelly-derived MSCs as part of its ulcerative colitis treatment program

Whether you're living with ulcerative colitis, researching stem cell therapy, or looking to better understand emerging regenerative medicine approaches, this episode breaks down the science behind UC-MSC therapy in clear and practical terms.

Blog Link: How Umbilical Cord MSCs May Influence Inflammation in Ulcerative Colitis

Transcript

SPEAKER_00 0:00

Welcome to the Cyrona Cell Podcast.

SPEAKER_01 0:02

Thanks for having me. It's uh it's great to be here to talk about this.

SPEAKER_00 0:05

Yeah, absolutely. So for today's mission, we're really taking a completely different perspective on how we approach, you know, chronic autoimmune conditions.

SPEAKER_01 0:13

Right. Getting away from just the standard symptom management.

SPEAKER_00 0:16

Exactly. We are specifically zeroing in on ulcerative colitis, or UC for short, and we're going on a deep dive to explore how um umbilical cord mesenchymal stem cells might actually hold the key to well, lowering inflammation in the gut.

SPEAKER_01 0:32

Aaron Powell And not just by masking those symptoms, but by actually retraining the body's entire defense network, which is, you know, a massive shift in thinking.

SPEAKER_00 0:41

It really is. I mean, for you for you listening, we're taking all of this directly from materials provided by Cyrus Cell, which is a regenerative medicine center.

SPEAKER_01 0:48

Right. Because for the longest time, medicine has kind of looked at ulcerative colitis as just this um mechanical failure of the gut, like something that just needs to be forcefully suppressed.

SPEAKER_00 0:59

Aaron Powell But the sources we're unpacking today, they highlight a biological approach that treats the gut more as the victim, right?

SPEAKER_01 1:05

Aaron Powell Yeah, exactly. The victim of a completely misguided immune system rather than the gut being the actual root source of the problem. Aaron Powell Right.

SPEAKER_00 1:13

And to give a little context on our sources, Cirona Cell is a doctor-led clinic based out of Cybergaya, Malaysia, which is just outside Kuala Lumpur.

SPEAKER_01 1:21

Aaron Powell Yeah. And they actually serve a really broad area.

SPEAKER_00 1:24

Aaron Ross Powell They do. They have a very global patient base, you know, people flying in from Australia, the Middle East, all over really for this medically supervised cell therapy.

SPEAKER_01 1:34

Trevor Burrus And their name is actually pretty interesting, right?

SPEAKER_00 1:36

Oh, yeah. Sorona comes from a Celtic goddess of health and protection, which I think really signals their focus on um careful, science-led care rather than those, you know, wild quick fix promises you sometimes see popping up on the internet.

SPEAKER_01 1:52

Aaron Powell Which is absolutely critical when you're talking about the regenerative medicine space. I mean, what really stands out in their clinical approach is that they view this therapy as an adjunct. Trevor Burrus, Jr.

SPEAKER_00 2:00

An adjunct, meaning it works with what you're already doing.

SPEAKER_01 2:04

Exactly. They're very clear that this operates alongside your standard specialist care. It's meant to communicate with your existing medical framework to target that root immune dysfunction.

SPEAKER_00 2:15

Okay, so um, before we get into how they do that, I have to ask a big pushback question. Sure, go for it. When you throw the term stem cells out there, my mind immediately goes to, well, some highly controversial places.

SPEAKER_01 2:28

Right. People immediately think of embryos.

SPEAKER_00 2:31

Exactly. Are we talking about embryonic stem cells here? Whose cells are these?

SPEAKER_01 2:36

It's probably the most important question to clarify right up front. We are absolutely not talking about embryonic stem cells.

SPEAKER_00 2:42

Okay, that's a relief.

SPEAKER_01 2:43

Yeah. And we aren't discussing those experimental lab-created plu pluripotent cells either. The protocols at Cirona Cell utilize ethically sourced WJMSCs.

SPEAKER_00 2:54

Okay, WJMSCs, you're gonna have to break that down for me.

SPEAKER_01 2:56

Aaron Powell Right. So the WJ stands for Wharton's Jelly.

SPEAKER_00 3:00

Or Wharton's Jelly.

SPEAKER_01 3:01

Yeah. It's this gelatinous tissue that basically surrounds and protects the blood vessels inside a human umbuccal cord.

SPEAKER_00 3:06

Oh wow. Okay.

SPEAKER_01 3:07

So after a healthy full-term baby is born, and you know, only with the explicit prior consent of the donor mother, this cord is collected.

SPEAKER_00 3:16

Aaron Powell So it's from healthy births.

SPEAKER_01 3:17

Exactly. Historically, hospitals just incinerated this as medical waste. So it's collected with zero harm to the mother or the child.

SPEAKER_00 3:25

Aaron Powell So we're taking this discarded tissue and extracting the mesenchymal stem cells, the MSCs, from it.

SPEAKER_01 3:32

Yep. That's the process.

SPEAKER_00 3:33

Aaron Ross Powell But I mean, I know you can get stem cells from a patient's own bone marrow, right? Or even their body fat. So why use the umbilical cord?

SPEAKER_01 3:42

Well, it really comes down to marrow cells have been studied for decades, but getting them requires literally drilling into bone.

SPEAKER_00 3:52

Uh which sounds incredibly painful.

SPEAKER_01 3:53

Aaron Powell It is a very painful invasive extraction. And biologically, think about it. If you're pulling cells from a 40-year-old patient, those stem cells are also 40 years old.

SPEAKER_00 4:03

Oh, right. I never thought about that.

SPEAKER_01 4:04

Aaron Ross Powell Yeah, they've been exposed to environmental toxins, stress, and whatever illness the patient is currently fighting. Trevor Burrus, Jr.

SPEAKER_00 4:10

So they're kind of beat up already.

SPEAKER_01 4:11

Aaron Powell Exactly. And fat-derived cells, well, they're easier to extract, but they just don't possess the same potent anti-inflammatory properties.

SPEAKER_00 4:19

Trevor Burrus, Jr. Okay. So if bone marrow cells are like the older, tired workers who need to be dragged out of bed to do a job.

SPEAKER_01 4:26

Yeah. That's a good way to put it.

SPEAKER_00 4:27

Aaron Powell And fat cells are maybe the weaker workers, then the umbilical cord cells from Wharton's jelly are basically the energetic new recruits.

SPEAKER_01 4:35

Aaron Powell They are. They're essentially day zero cells. Because they're so young, they divide much faster in culture, and they secrete massively higher levels of these healing factors that we're going to discuss.

SPEAKER_00 4:46

That makes a lot of sense.

SPEAKER_01 4:47

And um siren cell actually utilizes what are called early passage cells, all processed in CGMP and BSL2 certified labs.

SPEAKER_00 4:56

Aaron Powell Okay, pause. What does early passage mean? And then you'll have to translate those acronyms for me.

SPEAKER_01 5:00

Ha, fair enough. So early passage means the cells haven't been forced to replicate hundreds of times in a petri dish.

SPEAKER_00 5:07

Oh, like making copies of a copy.

SPEAKER_01 5:09

Exactly. If you photocopy a document too many times, the text gets blurry. It's the same with cells. Early passage ensures they keep their original potent biological programming. Got it.

SPEAKER_00 5:20

And the lab certifications.

SPEAKER_01 5:21

Right. So CGMP stands for current good manufacturing practice. It's a strict international standard for quality control. Okay. And BSL2 is biosafety level two, meaning they have really rigorous safeguards against contamination. Every batch gets obsessive testing for identity, sterility, and viability before it ever touches a patient.

SPEAKER_00 5:42

That's reassuring.

unknown 5:43

Yeah.

SPEAKER_00 5:44

You definitely want a clean, verified recruit.

SPEAKER_01 5:46

Absolutely.

SPEAKER_00 5:47

And because they are newborn cells, my understanding from the materials is that you don't even need to be a genetic match to receive them, right? They just fly right under the recipient's immune radar.

SPEAKER_01 5:56

Yeah, they have very low immune reactivity.

SPEAKER_00 5:58

But here is where my brain just gets stuck. The delivery method for this therapy is typically just a minimally invasive IV drip.

SPEAKER_01 6:05

Right. Standard IV.

SPEAKER_00 6:07

So the cells just go straight into a vein in your arm. But the circulatory system is this massive rushing highway. How in the world do cells in my arm know they're supposed to go fix the ulcers in my colon?

SPEAKER_01 6:20

It's a great question.

SPEAKER_00 6:21

I mean, why don't they just end up parked to my liver or something?

SPEAKER_01 6:24

Well, this brings us to one of the most elegant mechanisms in human biology. It's a process called homing.

SPEAKER_00 6:30

Combing.

SPEAKER_01 6:30

Yeah. And it relies entirely on a chemical gradient.

SPEAKER_00 6:34

A chemical gradient, like um like following a scent trail.

SPEAKER_01 6:37

Very much like that. When the tissue in the colon is being attacked and damaged by the immune system in UC, those dying cells don't just suffer quietly.

SPEAKER_00 6:46

They make some noise.

SPEAKER_01 6:47

They do. They release severe distress signals into the surrounding blood vessels. Specifically, they secrete a highly potent molecule called CXCL12.

SPEAKER_00 6:56

Okay, let's unpack this. Think of CXCL12 as a microscopic chemical flare, or like a 911 call from the gut.

SPEAKER_01 7:04

That's spot on. So the colon is popping these flares and the chemical is washing out into the bloodstream. Now, those umbilical cord stem cells are uniquely equipped with specialized surface receptors.

SPEAKER_00 7:14

Like little antennas.

SPEAKER_01 7:15

Exactly. The primary one is called CXCR4. You can visualize it just like an antenna sticking out of the stem cell, specifically tuned to detect that exact CXCL12 flare.

SPEAKER_00 7:28

That is just fascinating. So as these energetic new recruits are tumbling through the rushing river of your bloodstream, their antennas pick up this 9-11 signal.

SPEAKER_01 7:38

Yep.

SPEAKER_00 7:38

But how does that actually make them stop? I mean, they're moving fast. How do they exit the highway?

SPEAKER_01 7:43

Well, as the stem cell circulates closer to the colon, the concentration of that distress chemical gets thicker and thicker in the blood.

SPEAKER_00 7:50

Oh, so the scent gets stronger.

SPEAKER_01 7:51

Exactly. Once those antennas detect a high enough concentration, the stem cell actually physically alters its shape.

SPEAKER_00 7:58

Wait, really?

SPEAKER_01 7:58

Yeah, it flattens out, grips the endothelial wall of the blood vessel, and actively squeezes itself out of the bloodstream and directly into the inflamed colonic tissue.

SPEAKER_00 8:07

Just pulls itself right through the wall.

SPEAKER_01 8:08

It literally pulls itself toward the heaviest fighting.

SPEAKER_00 8:11

Wow. They are literally microscopic first responders.

SPEAKER_01 8:14

They really are.

SPEAKER_00 8:15

But wait, I was reading through the Nature Scientific Report study, included in our source stack, and um, I need you to clarify something because it completely upended how I thought this worked.

SPEAKER_01 8:25

Okay. What was it?

SPEAKER_00 8:26

These stem cells. Well, they don't actually move into the colon, plant themselves in the wall, and become terminant gut tissue, do they?

SPEAKER_01 8:34

No. No, they do not. And this is perhaps the biggest misconception surrounding regenerative medicine for autoimmune conditions.

SPEAKER_00 8:41

But people think it's like planting seeds.

SPEAKER_01 8:43

Exactly. But it's not about physically replacing damaged organs like putting a new alternator in a car. It's almost entirely about paracrine signaling. Yeah. Which basically means cell-to-cell communication.

SPEAKER_00 8:56

Aaron Powell Because the study showed that scientists could take just the MSC extract, right? Like basically just the chemical broth the cells secrete without any actual physical cells in it at all.

SPEAKER_01 9:07

Exactly.

SPEAKER_00 9:07

And they gave it to lab mice with colitis and saw almost the exact same healing response.

SPEAKER_01 9:12

Aaron Powell Which is the smoking gun, really? It proves that the magic isn't in the cell physically becoming a new piece of your colon. The magic is in the incredibly complex microscopic orders. Those cells are shouting to your existing immune system once they arrive on the battlefield.

SPEAKER_00 9:28

Okay, so they roll up to the inflamed colon, they take a look at the chaos, and they just start barking orders.

SPEAKER_01 9:34

Yep. They take charge.

SPEAKER_00 9:36

So let's get into the weeds here. What exactly are they saying and who are they talking to? Let's talk about these microscopic peacekeepers.

SPEAKER_01 9:42

So to understand the orders being given, we first have to look at the culprits driving the ulcerative colitis riot in the first place.

SPEAKER_00 9:48

The bad guys.

SPEAKER_01 9:49

Right. In your immune system, T cells are the generals. And in UC, a specific class called T helper cells, specifically TH1 and TH17, have gone completely rogue.

SPEAKER_00 10:01

So TH1 and TH17 are the guys with the megaphones inciting the riot.

SPEAKER_01 10:05

Exactly. They were the ones flooding the gut with pro-inflammatory cytokines, just hyping up the attack.

SPEAKER_00 10:11

But doesn't the body have a way to shut them down normally? I mean, we aren't all walking around with inflamed colons.

SPEAKER_01 10:16

It does. You have a counterforce called regulatory T cells, or T regs. Their entire job is to hit the brakes and enforce tolerance. Okay. But in a UC patient, the riot has basically overpowered the police. The pro-inflammatory cells are wildly overactive, and the regulatory T cells are suppressed and just totally exhausted.

SPEAKER_00 10:36

Wow. So our energetic recruits from the umbilical cord arrive via that homing beacon. How do they break up the fight?

SPEAKER_01 10:42

Aaron Ross Powell The MSCs act like a localized chemical factory. Once they're there, they begin pumping out the specific alphabet soup of immune modulating molecules.

SPEAKER_00 10:52

Oh, here come the acronyms again.

SPEAKER_01 10:53

Yeah. The major players are PGE2, TGF beta, and an enzyme called IDO.

SPEAKER_00 10:58

Aaron Powell Okay, let's break those down. What is that chemical bat actually doing to the riot?

SPEAKER_01 11:02

Aaron Powell It works on two fronts simultaneously. When those rogue TH1 and TH17 cells are bathed in molecules like TGF beta and IDO, it essentially acts as a molecular gag order.

SPEAKER_00 11:13

Aaron Powell A gag order. I like that.

SPEAKER_01 11:14

Yeah. It physically binds to the receptors and alters their internal signaling, basically forcing them to power down and start producing inflammation.

SPEAKER_00 11:21

So it takes away their megaphones.

SPEAKER_01 11:23

Exactly. And at the exact same time, that same chemical bath acts as a massive stimulant for the patient's native regulatory T cells.

SPEAKER_00 11:32

The peacekeepers.

SPEAKER_01 11:33

Right. It causes those exhausted peacekeepers to rapidly multiply.

SPEAKER_00 11:37

Okay. So they mute the rioters and multiply the peacekeepers. That's incredible.

SPEAKER_01 11:40

It is. But it actually goes deeper than T cells. We also have to talk about macrophages.

SPEAKER_00 11:46

Macrophages.

SPEAKER_01 11:46

Yeah. These are the white blood cells that act as the gut's frontline security guards. They actually roam around eating cellular debris and bacteria. Aaron Powell Yeah.

SPEAKER_00 11:55

From what I saw in the research, it looks like they have two distinct personalities, right? Yeah. Like an M1 and an M2.

SPEAKER_01 12:01

That is correct. M1 is the attack and destroy mode. M2 is the cleanup and repair mode.

SPEAKER_00 12:06

Okay, so they switch back and forth.

SPEAKER_01 12:07

In a healthy person, yes. A macrophage will switch to M1 to kill a bacteria, and then switch to M2 to clean up the mess and heal the tissue.

SPEAKER_00 12:16

But in ulcerative colitis.

SPEAKER_01 12:17

And you see those macrophages are permanently stuck in M1 attack mode.

SPEAKER_00 12:22

Oh no.

SPEAKER_01 12:22

Yeah, they become jagged, aggressive, and they constantly spit out highly damaging signals.

SPEAKER_00 12:28

Are those the signals the sources mentioned? Yeah. Um MCP-1 and ionos?

SPEAKER_01 12:33

Yes. Think of those as essentially molecular acid. They're breaking down the surrounding tissue to attack a threat that isn't really there.

SPEAKER_00 12:40

Wow. So if the macrophages are the security guards, in UC, they are completely hypervigilant. They think the building itself is the threat, so they're just smashing the walls.

SPEAKER_01 12:50

That's a perfect way to visualize it.

SPEAKER_00 12:52

So how do the stem cells fix a macrophage that's stuck in attack mode?

SPEAKER_01 12:56

Through a process called repolarization.

SPEAKER_00 12:58

Repolarization.

SPEAKER_01 12:59

Right. When the MSCs release factors like PGE2, it docks onto the surface of that stuck M1 macrophage. This docking triggers a cascade inside the macrophage's nucleus, literally forcing it to change its gene expression.

SPEAKER_00 13:13

It reprograms it on the spot.

SPEAKER_01 13:14

It physically alters its shape, stops producing that molecular acid, and switches it into M2 mode.

SPEAKER_00 13:19

So the stem cell basically walks up to the hypervigilant security guard, taps him on the shoulder, tells him to drop the sledgehammer, and hands them a broom.

SPEAKER_01 13:28

A broom in a first aid kit, really. Because once they're in M2 mode, those macrophages start pumping out IL-10.

SPEAKER_00 13:33

IL-10. What is that?

SPEAKER_01 13:35

Interleukin. It is one of the human body's most powerful anti-inflammatory cytokines. It's essentially heavy-duty fire retardant. Oh wow. And if we connect this to the bigger picture, this right here is why MSC therapy is fundamentally different from taking a standard immunosuppressant pill.

SPEAKER_00 13:54

Because a pill just suppresses everything.

SPEAKER_01 13:56

Exactly. A pill just acts like a blanket, smothering your entire immune system while the drug is circulating in your bloodstream. But the stem cells are interacting dynamically. They are actively retraining your own T cells and macrophages to behave correctly again.

SPEAKER_00 14:10

That is a brilliant distinction. It's not suppression, it's education.

SPEAKER_01 14:14

Precisely.

SPEAKER_00 14:14

Okay, so the stem cells have navigated to the gut, they've multiplied the regulatory peacekeepers, and they've handed brooms to the macrophage security guards. The riot is over.

SPEAKER_01 14:24

The riot is over.

SPEAKER_00 14:26

But we still have a major problem, right? The colon is still physically destroyed from the riot. The walls are in ruins.

SPEAKER_01 14:32

And if you don't rebuild the wall, the whole cycle will just start over. You have to repair what we call the intestinal epithelial barrier.

SPEAKER_00 14:38

Describe this barrier for me. I mean, what are we actually looking at under the microscope?

SPEAKER_01 14:43

The lining of your colon is incredibly fragile. It's actually just a single layer of epithelial cells. One single cell thick.

SPEAKER_00 14:52

That's it. Just one cell thick.

SPEAKER_01 14:54

That's it. That microscopic layer is the only thing standing between the sterile environment of your bloodstream and a colon filled with trillions of bacteria.

SPEAKER_00 15:03

That sounds precarious.

SPEAKER_01 15:04

It is. These cells are glued tightly together by proteins called tight junctions.

SPEAKER_00 15:09

Okay, so I picture it like a brick wall, and those tight junctions are the mortar holding the bricks flush against each other.

SPEAKER_01 15:15

Perfect visual. In ulcerative colitis, the constant inflammation acts like a pressure washer, completely blasting away that mortar. The tight junctions disintegrate.

SPEAKER_00 15:24

And when the mortar washes away, gaps open up, which means all those trillions of bacteria inside the colon suddenly have an open door into the tissue beneath the wall.

SPEAKER_01 15:34

Which instantly trips the immune system's alarm all over again. It's this vicious, self-reinforcing cycle.

SPEAKER_00 15:39

Aaron Powell So the standard drugs might put out the fire, but they don't fix the wall.

SPEAKER_01 15:43

Right. A lot of standard drugs are great at reducing the inflammation, but they don't actively bring new mortar to the construction site.

SPEAKER_00 15:50

Aaron Powell Which is where our umbilical cord cells step up for part two of their emission. So how do they physically rebuild this wall?

SPEAKER_01 15:58

The MSCs release a totally different set of signals this time, highly specific growth factors. The big three are HGF, EGF, and VEGF.

SPEAKER_00 16:06

Okay, alphabet soup time again. What do these growth factors actually do?

SPEAKER_01 16:11

Think of them as blueprints and supplies for different contractors. HGF is a parasite growth factor. It promotes cell migration.

SPEAKER_00 16:18

Migration, like moving cells around.

SPEAKER_01 16:20

Yeah, it essentially tells surviving healthy epithelial cells to stretch out and move across the gaps to cover the exposed tissue.

SPEAKER_00 16:27

Oh, like pulling a tarp over a hole in the roof.

SPEAKER_01 16:29

Exactly. Then you have EGF, epidermal growth factor. This stimulates cellular proliferation. It commands the tissue to generate brand new epithelial cells to permanently replace the ones that died.

SPEAKER_00 16:40

So laying down the new bricks.

SPEAKER_01 16:41

Yep. And finally, VEGF, vascular endothelial growth factor.

SPEAKER_00 16:45

Vascular implies blood vessels, right?

SPEAKER_01 16:47

Yes. VEGF signals the body to build tiny new blood capillaries in the damaged area. Healing tissue requires massive amounts of oxygen and nutrients. VEGF builds the supply lines to feed the construction site.

SPEAKER_00 17:01

This is wild. So they're pulling tarps over the holes, laying down brand new bricks, and building roads to bring in supplies.

SPEAKER_01 17:08

Pretty much.

SPEAKER_00 17:09

And I saw in the Serenicell materials that they also heavily support something called mucin production.

SPEAKER_01 17:14

Oh, yeah. That's crucial.

SPEAKER_00 17:16

What is mucin and why does it matter?

SPEAKER_01 17:18

Mucin is the primary component of mucus. In a healthy gut, a really thick layer of mucus coats the entire epithelial wall. Okay. It's the absolute first line of physical defense, keeping the bacteria from even touching the cells. By stimulating the goblet cells in the gut to pump out fresh mucin, the MSCs are essentially applying a thick, waterproof sealant over the newly repaired brick wall.

SPEAKER_00 17:40

Wow. So biologically we have a complete masterpiece happening here.

SPEAKER_01 17:44

It really is.

SPEAKER_00 17:45

The cells home in on the distress signal, they retrain the rogue immune cells, they generate new tissue, and they seal it all up. But you know, let's bring this out of the microscope and into the clinic. For you listening, how does this actually translate to a human being living with ulcerative colitis? How do doctors actually measure if this is working?

SPEAKER_01 18:05

The gold standard for measuring success in clinical trials is the disease activity index, or DAI.

SPEAKER_00 18:11

Okay, DAI.

SPEAKER_01 18:12

Right. It's a composite score. It isn't just about the patient subjectively saying, I feel better.

SPEAKER_00 18:17

They need hard numbers.

SPEAKER_01 18:18

Exactly. The DAI measures physical metrics, stool consistency, the frequency of bleeding, unintended weight changes, and the visual state of the colon. The lower the DAI score, the closer you are to normal.

SPEAKER_00 18:29

And what does the data actually show when patients receive these umbilical cord MSCs?

SPEAKER_01 18:35

The human clinical data is very compelling. Trials consistently report a 60 to 75% clinical response rate.

SPEAKER_00 18:42

That's a huge response rate.

SPEAKER_01 18:44

It is. That means a significant drop in that DAI score for the majority of patients. But more impressively, between 25 to 50% of patients achieve full clinical remission at the three-month mark.

SPEAKER_00 18:55

And clinical remission isn't just an absence of pain, right?

SPEAKER_01 18:58

No, it's confirmed by endoscopy. A gastroenterologist goes in with a camera and visibly confirms mucosal healing. The ulcers are gone, the wall is intact. That is amazing. Furthermore, if you pull blood work from these patients, you see a dramatic plunge in major inflammatory markers. Things like CRP and ESR, which measure systemic inflammation, they just drop significantly. Specific cytokine markers like TNF alpha and IL6 also plummet.

SPEAKER_00 19:27

Those are basically the smoke alarms in the bloodstream, and you can literally measure the smoke clearing out.

SPEAKER_01 19:32

That's a great way to put it.

SPEAKER_00 19:33

But here's the critical question for anyone considering this therapy at a place like Cyrenusel. Sure. What is the long game here? I mean, it is wonderful to heal at three months, but what happens at month 12? Does the immune system just forget the training and go rogue again?

SPEAKER_01 19:47

That is the beauty of immune retraining versus temporary suppression. Because the MSC has expanded your regulatory T cells and repolarized your macrophages, the benefits are incredibly durable.

SPEAKER_00 19:58

So it lasts.

SPEAKER_01 19:58

Yes. Long-term follow-up data shows that for patients who respond well, the clinical benefits often persist for twelve to twenty-four months after a single treatment cycle.

SPEAKER_00 20:08

Aaron Powell Up to two years of a calmed immune system from a therapy that essentially washes out of your body in a few weeks.

SPEAKER_01 20:15

Yes, because the stem cells themselves don't stick around, but the education they provided to your native cells remains.

SPEAKER_00 20:21

That's the retraining part.

SPEAKER_01 20:22

Exactly. And crucially, this long-term remission comes without the cumulative risks of standard heavy immunosuppressants.

SPEAKER_00 20:30

Right, because those can have harsh side effects.

SPEAKER_01 20:32

If you're on heavy biologics or steroids for years, you face cumulative risks of severe opportunistic infections or even certain malignancies. MSC therapy avoids that toxic compounding effect.

SPEAKER_00 20:44

Which brings up an interesting point. Can a patient do this if they are currently taking those standard medications?

SPEAKER_01 20:50

Absolutely. At clinics like Ceranocel, this is strictly positioned as an adjunct therapy.

SPEAKER_00 20:54

So they work together.

SPEAKER_01 20:55

In most cases, patients continue their existing biologics or anti-inflammatory meds while receiving stem cells. The medical team reviews the file to ensure there are no direct negative interactions.

SPEAKER_00 21:07

Like what?

SPEAKER_01 21:08

Well, for instance, extremely high doses of corticosteroids might inhibit the stem cells from functioning properly, so timing is key. But the ultimate long-term goal for many patients, in coordination with their primary gastroenterologist, is to use the cellular healing to eventually taper down those harsh standard medications.

SPEAKER_00 21:28

That makes total sense. And because this therapy is systemic, meaning the IV drip puts the cells into your entire circulatory system, it seems like there would be massive secondary benefits. Ulcerative colitis is famous for causing outside the gut symptoms, right?

SPEAKER_01 21:42

Oh, it really is. The same rogue immune cells damaging the colon often circulate and cause severe joint pain, skin rashes, or even eye inflammation. Right. Because the stem cells are circulating everywhere, they can detect those secondary chemical flares and calm inflammation systemically. This shared mechanism of action is exactly why these same WJMSCs are actively being studied and utilized for Crohn's disease as well. Plus, once you drop the systemic inflammation, your gut microbiome, the good bacteria, finally has a hospitable environment to re-establish itself.

SPEAKER_00 22:14

Which aids in digestion and just overall health.

SPEAKER_01 22:16

Exactly.

SPEAKER_00 22:17

It really is treating the entire ecosystem of the body rather than just patching the broken pipe.

SPEAKER_01 22:21

It's a total paradigm shift.

SPEAKER_00 22:22

So to bring it all together for you listening, we start with these energetic day zero umbilical cord cells, rigorously and ethically prepared at regenerative centers like Cironacell.

SPEAKER_01 22:33

Yep.

SPEAKER_00 22:34

They enter your bloodstream, pick up on the chemical distress signals radiating from your colon, and navigate straight to the war zone. They don't become your colon. Instead, they act as master communicators. Right. They mute the rioting T cells, they hand brooms to the macrophage security guards, and they release growth factors to physically lay new bricks and seal the gut wall, leading to deep, measurable, and durable remission.

SPEAKER_01 22:59

And you know, when you look at the sheer intelligence of that cellular communication, it opens up a fascinating, almost science fiction level question for the future of medicine.

SPEAKER_00 23:08

Oh, what's that?

SPEAKER_01 23:09

Well, we just spent this entire time talking about how these cells use a chemical gradient to cross out of the bloodstream and into the inflamed tissue of the gut.

SPEAKER_00 23:18

Right, the homing mechanism.

SPEAKER_01 23:19

Exactly. But researchers are now looking at other seemingly impenetrable barriers in the body. If these WJMSCs are this incredibly adept at tracking down local inflammation and resetting rogue immune cells, could this same exact homing mechanism eventually be utilized to cross the blood-brain barrier?

SPEAKER_00 23:39

Wow.

SPEAKER_01 23:39

Could we one day use these newborn cells to track down and reset the neuroinflammation driving diseases like Parkinson's or Alzheimer's? It suggests that the gut might just be the proving ground for a much larger revolution in how we heal the human brain.

SPEAKER_00 23:53

Crossing the blood-brain barrier with targeted biological peacekeepers. That is a phenomenal thought to end on, and really a perfect example of why this field is moving so incredibly fast.

SPEAKER_01 24:03

It's an exciting time for medicine.

SPEAKER_00 24:04

It really is. The body has the capacity to remember how to heal. Sometimes it just needs the right microscopic translation to get back on track. Thank you for joining us on this deep dive into the science of regenerative medicine. Keep asking questions, keep exploring the research, and we'll catch you next time.